MaxCyte
MXCT
120 hedge funds and large institutions have $201M invested in MaxCyte in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 12 closing their positions.
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
3% more funds holding
Funds holding: 116 → 120 (+4)
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
1.99% less ownership
Funds ownership: 64.16% → 62.17% (-2%)
34% less capital invested
Capital invested by funds: $303M → $201M (-$103M)
90% less call options, than puts
Call options by funds: $3K | Put options by funds: $31K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$7.68M |
| 2 |
MA
Mudita Advisors
London,
United Kingdom
|
+$2.26M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.99M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.92M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
+$821K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$11.4M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$5.71M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$3.15M |
| 4 |
Morgan Stanley
New York
|
-$1.19M |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$957K |
MXCT Hedge Fund Activity: Q3 2023 in Review
120 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2023, worth a combined $201M — down 34% from $303M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MXCT positions and 12 closed out — a net gain of 5 holders — while 42 added to existing stakes and 39 trimmed.
The largest buyer was Millennium Management, adding an estimated $7.68M. The largest seller was Casdin Capital, cutting an estimated $11.4M.
- 120 institutional investors held MaxCyte (MXCT) as of Q3 2023, up from 116 in Q2 2023.
- Funds reported $201M of MaxCyte stock for Q3 2023, down 34% quarter-over-quarter.
- 17 funds opened new MaxCyte positions in Q3 2023 and 12 closed out, a net change of +5 holders.
- The largest MaxCyte buyer in Q3 2023 was Millennium Management, an estimated $7.68M added.
- The largest MaxCyte seller in Q3 2023 was Casdin Capital, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2023.